Population Pharmacokinetics of CS1001, an Anti-Programmed Death-Ligand 1(PD-L1) Human Monoclonal Antibody(mAb), in Patients with Advanced-Stage Solid Tumor or Relapsed or Refractory Extranodal Natural Killer/T cell Lymphoma
作者:|发布:Xiaoyi Yu, Wang Kun, Yucheng Gao,et al.|发布时间: 2022-06-20|414 次浏览|分享到:
Chinese clinical oncology. ISSN:1009-0460, cn 32-1577/R, Page:515-516.
